| Structure |
Chemical Name |
CAS |
MF |
 |
溶剤脱ワックス重質飽和炭化水素石油蒸留物 |
64742-65-0 |
|
 |
4-(4-chlorophenyl)-5-methyl-3-phenylisoxazole |
1448355-87-0 |
C16H12ClNO |
 |
(E)-4-アミノクロトン酸 |
38090-53-8 |
C4H7NO2 |
 |
EsoMeprazole iMpurity |
1424857-86-2 |
C11H15NO3 |
 |
Clindamycin Impurity F |
|
|
 |
Irbesartan Impurity 6 |
|
C25H28N6O |
 |
Rosuvastatin Impurity 131 |
|
|
 |
Carfilzomib Impurity D |
|
|
 |
ゾルピデム6-カルボン酸 |
109461-15-6 |
C19H19N3O3 |
 |
N-((S)-1-(((R)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
289472-78-2 |
C19H24N4O3 |
 |
Mixed gas of propane, carbon monoxide and carbon dioxide |
|
|
 |
Azlocillin Opern-Ring Acetylation Impurity |
|
|
 |
Tolterodine Impurity 1 |
88407-28-7 |
C22H31NO |
![2-((chloro(3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-5- (difluoromethoxy)-1Na-benzo[d]imidazole](/) |
2-((chloro(3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-5- (difluoromethoxy)-1Na-benzo[d]imidazole |
|
|
![2,4(1H,3H)-Pyrimidinedione, 3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-](/CAS/20200331/GIF/2354391-45-8.gif) |
2,4(1H,3H)-Pyrimidinedione, 3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl- |
2354391-45-8 |
C13H10F4N2O2 |
 |
Oseltamivir Impurity 108 |
|
|
 |
Lansoprazole IMpurity I |
|
|
 |
5,9,13,17-Nonadecatetraen-2-one, 6,10,14,18-tetramethyl-, (Z,E,Z)- (8CI) |
3879-25-2 |
C23H38O |
 |
Cefamandole Impurity A |
1947364-12-6 |
C17H16N2O6S |
 |
CHEMPACIFIC 59929 |
856240-62-5 |
C18H24O4 |
 |
5-Fluoro ent-LaMivudine Acid D-Menthol Ester |
764659-79-2 |
C18H26FN3O4S |
 |
Furosemide Impurity 2 |
|
C12H11ClN2O5S |
 |
Febuxostat impurity BAC |
|
|
 |
Perospirone Impurity 3 |
1002359-81-0 |
C8H11NO2 |
 |
Olaparib Impurity Q |
|
|
 |
Itraconazole iMpurity 5 |
|
|
![1(2H)-Naphthalenone, 4-hydroxy-3-methyl-2-[(2E,6E,10E)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraen-1-ylidene]-](/CAS/20210305/GIF/693781-59-8.gif) |
1(2H)-Naphthalenone, 4-hydroxy-3-methyl-2-[(2E,6E,10E)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraen-1-ylidene]- |
693781-59-8 |
C31H40O2 |
 |
Moxifloxacin Impurity 14 |
|
|
 |
Bortezomib Impurity G Complete Set |
|
|
 |
Peramivir Impurity 55 |
|
|
 |
Carbazochrome Sodium Sulfonate Impurity IV (Carbazochrome Sodium Sulfonate Impurity 4) |
|
|
 |
Roxadustat Impurity 16 |
|
|
 |
Dapoxetine Impurity D |
|
|
![1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-](/CAS/20210305/GIF/1642569-42-3.gif) |
1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo- |
1642569-42-3 |
C20H17N5O5 |
 |
Exemestane Impurity 1 |
159354-61-7 |
C20H24O3 |
 |
Vinpocetine |
80038-06-8 |
C22H26N2O2 |
 |
Mirabegron Impurity 21 |
|
|
 |
Cefazolin Impurity EP-E |
|
|
![Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-, hydrochloride (1:)](/CAS/20211123/GIF/571189-66-7.gif) |
Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-, hydrochloride (1:) |
571189-66-7 |
C22H28ClN7O |
 |
Tazobactam Impurity C |
|
|
 |
Afatinib impurity 49 |
|
|
 |
3-Pyrazolidinone, 5-cyclopentyl-, (5R)-, (2S,3S)-2,3-dihydroxybutanedioate (1:1) |
2102675-37-4 |
C12H20N2O7 |
 |
5-Decyano 5-(Ethyl Formate) Milrinone |
80442-07-5 |
C14H14N2O3 |
![(3S)-9,10-difluoro-3-methyl-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid](/CAS/20180703/GIF/1026952-91-9.gif) |
(3S)-9,10-difluoro-3-methyl-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
1026952-91-9 |
C13H11F2NO4 |
 |
Carbazochrome Sodium Sulfonate Impurity I |
|
|
 |
1,2-Bis(piperazin-1-yl)benzene |
1446750-99-7 |
C14H22N4 |
 |
PERINDOPRIL IMPURITY A |
|
|
 |
Nicergoline Impurity G |
|
|
 |
Lenacapavir impurity |
3060953-29-6 |
C39H32ClF10N7O5S2 |
 |
tert-butyl (4-(4-(3-chloroazetidin-1-yl)piperidin-1-yl)-2-methoxy-5- nitrophenyl)carbamate |
|
|
 |
Metoprolol IMpurity L |
|
C15H25NO3 |
 |
Isavuconazole Impurity 4 |
|
|
 |
Lenvatinib Impurity 31 |
|
|
 |
Lamivudine Impurity 4 |
|
|
 |
アゾベンゼン-2-オール |
2362-57-4 |
C12H10N2O |
 |
Sertraline Impurity 20 |
1498236-91-1 |
C16H14Cl2O |
 |
3-THIOPHENEPROPANAMINE, N,N-DIMETHYL-GAMMA-(1-NAPHTHALENYLOXY)-, ETHANEDIOATE(1:1) |
116817-26-6 |
C19H21NOS.C2H2O4 |
 |
Elagolix Sodium impurity3 |
|
|
 |
Tenofovir Impurity 54 |
|
|
 |
1175018-73-1 |
1175018-73-1 |
C12H14ClN |
 |
Iohexol related Compound I |
|
|
 |
Empagliflozin Impurity 89 |
2452301-32-3 |
C23H25ClO7 |
 |
Pregabalin Impurity 32 |
|
|
 |
Flomoxef Impurity I |
|
|
 |
Linagliptin Impurity 30 |
2074688-81-4 |
C33H32N8O5 |
 |
Ozagrel Impurity 2 |
|
|
![[(5Z)-5-ベンジリデン-4-オキソ-2-チオキソ-1,3-チアゾリジン-3-イル]酢酸](/CAS/GIF/82159-06-6.gif) |
[(5Z)-5-ベンジリデン-4-オキソ-2-チオキソ-1,3-チアゾリジン-3-イル]酢酸 |
82159-06-6 |
C12H9NO3S2 |
 |
Brexpiprazole Impurity ABCDEFGHJKL |
|
|
 |
Sorafenib related compound 12 |
284461-74-1 |
C20H14ClF3N4O3 |
 |
(2-(methyl((vinyloxy)carbonyl)amino)pyridin-3-yl)methyl 2-(methylamino)acetate hydrochloride |
|
|
 |
Olaparib Impurity C |
|
|
 |
Palonosetron Impurity TM1-YA |
|
|
![N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine](/CAS/20180629/GIF/1052691-22-1.gif) |
N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine |
1052691-22-1 |
C10H19N3S |
 |
(2R,3R,4R,5S)-5-(4-benzaMido-2-oxopyriMidin-1(2H)-yl)-2-((benzoyloxy)Methyl)-4-fluoro-4-Methyltetrahydrofuran-3-yl benzoate |
874638-94-5 |
C31H26FN3O7 |
 |
Butyphthalide impurity 35 |
|
|
 |
Budesonide Impurity 26 |
|
|
 |
Aprepitant |
1242175-38-7 |
C20H18F7NO2 |
 |
Sugammadex sodium Impurity 43 |
|
|
 |
(1-carboxy-1-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)ethyl)-L-cysteine |
|
|
 |
Clopidogrel Impurity 13 |
2173294-69-2 |
C16H16ClNO5S2 |
 |
Doxofylline Impurity 11 |
109403-76-1 |
C15H16N8O4 |
![(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole](/CAS/20210111/GIF/65576-39-8.gif) |
(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole |
65576-39-8 |
C17H17NO |
 |
Varenicline Impurity 5 |
950781-87-0 |
C11H13N3O2 |
 |
NSC 609249 |
51012-67-0 |
C12H20ClNO2 |
 |
Pralatrexate Impurity 13 |
|
|
![Benzonitrile, 4-[2-[(1R,2S)-2-(2,5-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]-, rel-](/CAS/20210305/GIF/1797905-83-9.gif) |
Benzonitrile, 4-[2-[(1R,2S)-2-(2,5-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]-, rel- |
1797905-83-9 |
C22H17F2N5OS |
 |
Ozagrel Impurity 1 |
|
|
 |
Caspofungin IMpurity A |
1202167-57-4 |
C51H86N10O15 |
![2-chloro-1-(5-hydroxy-5H-chromeno[2,3-b]pyridin-7-yl)propan-1-one](/) |
2-chloro-1-(5-hydroxy-5H-chromeno[2,3-b]pyridin-7-yl)propan-1-one |
|
|
 |
Dextrorotation lansoprazole Impurity K |
|
|
 |
Fluconazole Impurity 2 |
|
|
 |
Parecoxib Sodium Imp.E |
|
|
 |
Tazobactam Impurity 4 |
|
|
 |
Letermovir Impurity 2 |
|
|
 |
Empagliflozin Impurity 62 |
1620758-30-6 |
C23H27ClO8 |
 |
(S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-hydroxybut-2-enamide |
|
|
 |
Donepezil Impurity |
896134-06-8 |
C17H15NO4 |
 |
Carfilzomib Impurity 6 |
|
|
 |
Tazobactam Impurity LTE |
|
|
![9-[(Z)-1-プロペニル]-9H-プリン-6-アミン](/CAS/20180703/GIF/1464851-21-5.gif) |
9-[(Z)-1-プロペニル]-9H-プリン-6-アミン |
1464851-21-5 |
C8H9N5 |